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Abstract
Roles for hypothalamic reactive oxygen species (ROS) in the modulation of circuit activity of the
melanocortin system were proposed1,2,. Here we show that suppression of ROS diminished pro-
opiomelanocortin (POMC) cell activation and promoted the activity of neuropeptide Y- (NPY)/
agouti related peptide- (AgRP) neurons and feeding, whereas ROS activated POMC neurons and
reduced feeding. ROS in POMC neurons were positively correlated with leptin levels in lean and
ob/ob animals a relationship diminished in diet-induced obese (DIO) mice. High fat feeding
resulted hypothalamic proliferation of peroxisomes and elevated PPARγ mRNA levels.
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Peroxisome proliferation in POMC neurons by the PPARγ agonist, rosiglitazone, decreased ROS
levels and increased food intake in lean mice on high fat diet. Suppression of peroxisome
proliferation in the hypothalamus by the PPAR antagonist, GW9662, increased ROS and c-fos
expression in POMC neurons, reversed high fat feeding-triggered elevated NPY/AgRP and low
POMC neuronal firing, and, resulted in decreased feeding of DIO mice. Finally, central
administration of ROS alone increased c-fos and pStat3 expression in POMC neurons and reduced
feeding of DIO animals. These observations unmask a previously unknown hypothalamic cellular
event associated with peroxisomes and ROS in the central regulation of energy metabolism in
states of leptin resistance.
Much has been learned about the control of feeding behavior and of its neuronal substrate in
the hypothalamus, the melanocortin system3,4,5,6. One of the remaining enigmas is the
neurobiological substrate of leptin resistance, a mechanism that entails the inability of
increased leptin levels to promote a decreased feeding and body weight in diet-induced
obese subjects7. Many have argued that leptin resistance is the consequence of impaired
activation of anorexigenic POMC neurons by elevated leptin levels during obesity, and that
this mechanism involves altered intracellular signaling cascades, including activation of
Socs 38. However, there is no conclusive neurobiological proof for impaired synaptic
transmission in the melanocortin system in diet-induced obese animals9,10. Indeed, several,
neurobiologically relevant components of the melanocortin system do not exhibit a clear
leptin resistance9,11. Thus, the underlying cause for the impaired correlation between
elevating leptin levels, POMC neuronal activity and feeding during diet-induced obesity
remains elusive.
We observed that central scavenging of ROS is permissive of AgRP neuronal firing and
promotion of feeding, while activity of POMC neurons and satiety is associated with
increased intracellular ROS levels1,2. These observations on circuit function regulated by
ROS1,2 together with the reported effect of hypothalamic ROS in glucose- and lipid-
sensing12,13 made us explore whether regulation of ROS plays a role in the development of
impaired melanocortin tone in diet-induced obesity.
First, we analyzed the effect of a ROS scavenger on POMC neuronal activations and feeding
in wild type animals (Fig. 1). We observed that intracerebroventricular (icv.) administration
of the ROS scavenger, honokiol,14 resulted in significantly elevated (67.00%±8.02 SEM vs.
14.33%±6.29SEM; P<0.01) c-fos expression in NPY/AgRP and significantly neurons lower
(16.54%±7.33SEM vs. 57.01%±4.85SEM, P<0.01) c-fos expression in POMC neurons
compared to vehicle treated controls (Fig. 1a, b). The same treatment caused elevated food
intake during the light cycle compared to vehicle controls (1h: 0.17g±0.05SEM vs. 0.01g
±0.01SEM; 2h: 0.21g±0.04SEM vs. 0.01g±0.01SEM; 4h: 0.31g±0.08SEM vs. 0.06g
±0.04SEM; 8h: 0.46g±0.11SEM vs. 0.1g±0.08SEM; P<0.05) (Fig. 1c). These observations
are in line with our earlier findings1, and, they revealed that suppression of ROS inhibits
POMC neuronal activity as assessed by c-fos expression.
Next, we tested the effect of promotion of ROS generation on POMC neuronal activity ex
vivo and feeding behavior in vivo. We conducted patch-clamp whole cell
electrophysiological recordings in slice preparations from POMC-GFP mice with and
without H2O2 application. 1μM H2O2 depolarized POMC neurons (Fig. 1d) and increased
the firing rate of these cells (Fig. 1d). In line with these neurobiological effect in the arcuate
nucleus, i.c.v. injection of 5μM H2O2 in 2 μl caused decreased (P<0.01) feeding of mice
after an overnight fast compared to vehicle-injected controls (Fig. 1e). This effect of H2O2
on promotion of decreased feeding is in line with the effect of ROS in glucose sensing and
experimental hypertriglyceridemia and.12,13 Taken together these observations provide
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evidence that ROS can be an acute regulator of POMC neuronal activity and that exogenous
ROS administered to the brain can promote satiety in lean mice.
We next analyzed ROS levels in POMC cells using DHE from animals with normal
metabolism (fed and fasted wild type mice) and from animals with impaired POMC
neuronal activity (ob/ob and diet-induced obese (DIO) mice). We found the lowest level of
DHE in POMC neurons of ob/ob mice (4.96±0.23SEM fluorescent particles per 10μm2 of
cytosol) and wild type mice that were fasted overnight (5.16±0.48SEM) (Fig. 1f, g). On the
other hand, 48 h of leptin treatment10 of ob/ob mice resulted in elevation in DHE levels in
POMC neurons compared to PBS-treated controls (16.25±1.15SEM vs. 7.5±1.32SEM
fluorescent particles in 10μm2 cytosol; P<0.05). DHE levels were significantly (P<0.001)
higher in fed wild type animals (14.79±0.83SEM) and in DIO mice (16.61±0.98SEM) (Fig.
1f, g) compared to fasted wild type and untreated ob/ob values. However, there was no
statistically significant difference between POMC DHE levels between fed and DIO mice
(Fig. 1f, g). The lack of difference in POMC ROS levels between fed (lean) and DIO
animals was associated with almost 3 fold higher levels of circulating leptin in DIO animals
compared to lean fed mice (Fig. 1h). Thus, while there is a positive correlation between
circulating leptin levels and ROS levels in POMC neurons of fasted and ob/ob animals, in
DIO animals, substantially higher levels of circulating leptin had no proportional increase in
ROS levels in POMC neurons (Fig. 1g, h).
The dissociation of elevated leptin levels from increased POMC ROS content in DIO mice
could involve multiple mechanisms, including a putative role for mitochondrial uncoupling
protein 2 (UCP2).1,15 We noted the presence of peroxisomes in POMC neurons.
Peroxisomes are intracellular organelles involved with non-ATP generating lipid beta
oxidation and control of ROS16. We evaluated the number of mitochondria and peroxisomes
in POMC neurons of ob/ob, fasted lean, fed lean and DIO animals. We found the lowest
number of mitochondria (0.8±0.06SEM mitochondria per 1 μm2 cytosol) and peroxisomes
(0 persoxisome per 1 μm2 cytosol) in the cytosol of POMC in ob/ob animals (Fig. 2a–c).
Lean fed mice had higher mitochondria number (2.19±0.27SEM) compared to fasted
(0.98±0.13SEM) and ob/ob animals (Fig. 2b), but peroxisome numbers were not different in
fed (0.18±0.04SEM) and fasted mice (0.14±0.01SEM) (Fig. 2c). While mitochondria
number was not different in POMC neurons of DIO mice (2.3±0.42SEM) from that of fed
animals (Fig. 2b), peroxisome counts were almost 3 fold higher in POMC neurons of DIO
mice (0.39 ±0.04SEM) compared to the values of lean fed animals (Fig. 2c). Through
analysis of 50 POMC neurons (10 cells analyzed per animal; n=5)17 peroxisomes were not
found in POMC neurons of db/db mice (Supplementary Fig. 1 online). We also analyzed
peroxisome number in NPY/AgRP neurons. We found that peroxisome number was
significantly higher in AgRP neurons of DIO mice compared to lean values (Supplementary
Fig. 2 online). Taken together these observations suggest that peroxisomes may render
melanocortin neurons less active in DIO animals decreasing the ability of elevated leptin to
promote POMC neuronal activity and satiety.
Proliferation of peroxisomes is governed, in part, by nuclear receptors, such as peroxisome
proliferating receptor gamma (PPARγ)18. PPARγ was associated with brain inflammation,
gliosis19 and ROS control20 mechanisms that are characteristic of the arcuate nucleus of
DIO animals (present study and 9,21). PPARγ was detected in the brain22 and in neurons of
the arcuate nucleus23. We analyzed transcript levels in the hypothalamus of PPARα, δ, and
γ and some of their putative target genes. PPARγ mRNA was several fold higher in the
hypothalamus compared to PPARα or δ mRNA (Fig. 2d). In DIO mice, hypothalamic
transcripts of PPARγ but not PPARα or δ were up-regulated compared to lean controls
(Fig. 2e). DIO hypothalamus also showed elevated liver X receptor alpha (LXRa) and
glucokinase transcript levels (Fig. 2e). This constellation of transcript inductions in DIO
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mice is in line with both increased carbohydrate and lipid metabolism in the hypothalamus
in response to high fat feeding and with processes uncovered in the liver24.
Next we analyzed PPARγ transcript levels in POMC and AgRP neuronal cell lines,25.
PPARγ transcripts were identified in both neuronal cultures (Fig. 2f for POMC cultures;
data not shown for NPY cultures). Treatment of the cultures with 10 μM of the PPARγ
agonist, pioglitazone (Sigma), for 24 hrs resulted in elevated expression of the PPARγ
target gene26, glycerol-3-phosphate dehydrogenase 1 (Gpd1) in POMC neurons (Fig. 2g),
and expression of mRNA encoding fatty acid binding protein 4 (Fabp4) and perilipin 2
(Plin2) in NPY neurons (Fig. 2h, i). Thus, high fat feeding-inducible hypothalamic PPARγ
is expressed in in key neurons of the melanocortin system, and, it can be activated by
selective agonists.
In ob/ob hypothalamus, it was PPARδ mRNA that was elevated together with transcripts
classically characteristic of pre-adipocites such as, cell death-inducing DNA fragmentation
factor alpha-like effector A (CIDEA)27 and adipose differentiation-related protein (ADFP or
adipophilin) (Fig. 2j)28. Thus, obesity in ob/ob animals has differential cellular pressure on
hypothalamic neurons compared to DIO animals.
Next we tested whether chemical agonists and antagonists of PPARγ29 may impact
peroxisome number, ROS levels and feeding in lean and DIO mice. We analyzed animals
(lean and DIO mice) while on high fat diet, because previous studies,30 as well as the
present study (data not shown) revealed no effect of PPARγ agonists or antagonists on
feeding of animals on normal chow. We i.c.v. injected lean mice after 5 days on HFD with
PPARγ agonist, rosiglitazone, twice a day for 7 days and DIO mice with 0.5 μg of the
PPARγ antagonist, GW9662 (Sigma–Aldrich Corporation, St. Louis, MO, USA) twice a
day for 7 days. We i.c.v. injected control animals for both groups with equivalent volume of
the diluent. In similar cohorts of animals, we injected DHE in the last day of the treatment to
analyze ROS levels in POMC neurons. Seven day i.c.v. rosiglitazone treatment of lean mice
resulted in significantly elevated peroxisome number in POMC neurons compared to
controls (Rosi: 0.41+0.05SEM vs. vehicle: 0.15+0.02SEM; P<0.05), which was
accompanied by decreased appearance of ROS in these neurons (Rosi: 9.03±0.26SEM;
vehicle: 17.55±0.4SEM; P<0.05), and increased daily food intake (4.28g+0.14SEM vs.
3.43g+0.18SEM; P<0.05) (Fig. 3a–g). In contrast, 7 day treatment of DIO mice with the
PPARγ antagonist, GW9662, resulted in lower number of peroxisomes in POMC neurons
compared to controls (GW9662: 0.17+0.02SEM; vehicle: 0.4+0.05SEM; P<0.05), with
elevated DHE levels (GW9662: 27.45±2.92SEM; vehicle: 18.31±0.66SEM; P<0.05) and
lower daily food intake (GW9662: 2.29g+0.1SEM, vehicle: 2.92g±0.11SEM; P<0.05) (Fig.
3a–g). These observations are consistent with two recent reports showing that interference
with neuronal PPARγ signaling has no detectable phenotype on standard chow, but
attenuates DIO.31,32
To further test the relationship PPARγ and peroxisomes, we analyzed the expression of a
key peroxisomal enzyme, catalase, in hypothalami of neuron-specific PPARγ knockout
mice31 and wild type littermates. After 2 weeks on high fat diet, wild type animals exhibited
significantly higher number of catalase-immunopositive arcuate nucleus cells compared to
PPARγ knockout mice (51.75+5.75 cells/0.0025mm3 of arcuate nucleus versus 12.75+3.75
cells/0.0025mm3 of arcuate nucleus; P<0.05; Supplemental Fig. 3 online). This data
corroborates a role for PPARγ in peroxisome proliferation in the hypothalamus.
To test whether interference with PPARγ activity affects neurobiological correlates of
feeding regulation, first we analyzed c-fos expression in POMC neurons of vehicle-,
rosiglitazone- and GW9662-treated female mice on high fat diet. While rosiglitazone did not
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affect the number of c-fos expressing POMC neurons, GW9662 treatment resulted in a
significant (P<0.05) induction of c-fos in melanocortin cells compared to DIO control values
(Fig. 3h, i; Supplementary Fig. 4 online).
Because GW9662 induced c-fos expression in POMC neurons, and because peroxisome
number and PPARγ signaling were induced also in NPY neurons, we next analyzed electric
activity of NPY/AgRP and POMC neurons in GFP-NPY and GFP POMC DIO mice with or
without GW9662 treatment. Firing rate of NPY/AgRP and POMC neurons were measured
on slices taken at 10:00AM from GW9662 or vehicle-treated DIO mice. This time point of
the day represents relative satiety with high POMC and low NPY/AgRP neuronal firing of
standard chow fed mice.14,32 In contrast to chow fed mice, in vehicle-treated DIO animals,
analysis of action potential frequency at 10:00AM revealed elevated NPY/AgRP neuronal
firing and low POMC firing (Fig. 4a, b). The level of NPY/AgRP neuronal firing in fed DIO
mice was not dissimilar from the firing frequency recorded in these neurons during
fasting.33 The low firing of POMC neurons at the time of relative satiety in DIO mice is
consistent with the measured lower α-melanocyte stimulating hormone (α-MSH) release by
hypothalamic explants of the DIO mice.15 Of note, i.c.v. GW9662 treatment significantly
(P<0.05) reversed this DIO-induced firing alteration of the melanocortin system, whereby
NPY/AgRP neurons reduced their firing rate and POMC neurons increased action potential
generation (Fig. 4a, b). In DIO animals, very few NPY/AgRP neurons were silent, but this
number was elevated after GW9662 treatment (Fig. 4c). On the other hand, while more then
half of the POMC neurons were silent (not firing at all) in vehicle-treated DIO mice, this
population was lower after GW9662 treatment (Fig. 4d). Thus, GW9662 reversed firing of
both NPY/AgRP and POMC neurons in DIO animals to resemble the firing rates of these
cells in lean animals at a time of satiety on normal chow.15,33
ROS was elevated by GW9662 treatment and readily enhanced POMC neuronal firing (Fig.
1). To test whether ROS may be a mediator of the effects of PPARγ, we next analyzed the
effect of rosiglitazone and GW9662 in animals on high fat diet with and without i.c.v. H202
and honokiol administration, respectively. We found that 5 day treatment-induced changes
in feeding of high fat fed animals by rosiglitazone or GW9662 were diminished by
subsequent 2 day parallel i.c.v. administration of H202 or honokiol, respectively (Fig. 4e, f).
Thus, alteration of PPARγ signaling may exert its effect on hypothalamic regulation of
feeding via ROS. To further test this, we analyzed the effect of GW9662 and rosiglitazone in
UCP2 knockout mice, an animal model that had endogenously elevated hypothalamic ROS
levels.1 We found no significant effect of either GW9662 or rosiglitazone on feeding of
these animals (Supplementary Fig. 5 online). The lack of effect rosiglitazone in UCP2
knockout mice is in line with inhibitory effect of ROS on rosiglitazone. GW9662 may not
have been effective because there were very few peroxisomes in POMC neurons of UCP2
knockout mice (Supplementary Fig. 5 online).
To test whether ROS alone could reverse POMC function, we injected H202 i.c.v. in DIO
mice. We found that i.cv. H202 resulted in elevated c-fos expression in POMC neurons (Fig.
3h, i and Supplementary Fig. 4d online), lower feeding (Fig. 4g) and elevated pStat3
expression in response to peripheral leptin injection compared to controls (Fig. 4h). We
found 3% POMC (3 out of 100 POMC perikarya from 5 animals) to contain pStat3, while in
H202-treated DIO mice, 18% of POMC cells (18 out of 100 POMC perikarya from 5
animals) were immunolabeled for pStat3. These observations suggest that while ROS
enhances leptin sensitivity in DIO animals, ROS’ effect on feeding may be downstream
from leptin signaling, a notion consistent with the electric actions of H2O2 on POMC
neurons (Fig. 1). How other intracellular controllers of ROS interact to set metabolically and
functionally relevant cellular ROS levels will need further studies.
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Our studies established that ROS is an acute activator of POMC neuronal firing, and that in
lean animals, hypothalamic ROS is positively correlated with circulating leptin level. ROS
levels are controlled in hypothalamic POMC neurons of DIO animals in association with
peroxisome proliferation. This novel metabolically regulated intracellular mechanism can be
regulated by PPARγ activity, which, itself is under nutritional control in the hypothalamus.
Peroxisome proliferation in the hypothalamus is consistent with the origin of peroxisomes
from the endoplasmic reticulum under increased metabolic pressure34,35 as endoplasmic
reticulum stress was identified as contributor to DIO-related leptin resistance36. Our results
argue for endogenous ROS control during diet-induced obesity as a potential cause of
functional leptin resistance manifested by lower POMC and elevated NPY/AgRP neuronal
firing. In light of the deleterious effects of sustained elevated ROS levels37, our study gives
support to the notion that promotion of sustained satiety through the brain in diet-induced
obese may increase degenerative processes2.
Methods
All procedures described below have been approved by the Institutional Animal Care and
Use Committee of Yale University. Mice were kept under standard laboratory conditions
with free access to food and water. All experiments described below were conducted on
C57Bl6 (and ob/ob when specified) male and female mice maintained on either NPY-GFP,
POMC-GFP or UCP2 knockout mice.1,10 Regular diet: Purina Lab Chow #5001, Ralston
Purina Corp, St. Louis, MO. HFD: Rodent Chow #D12451, Research Diets Inc., New
Brunswick, NJ. HFD was fed for 12 weeks starting at 6 weeks of age. Daily food intake was
assessed in individually housed mice.
Lateral ventricle canullation
A sterile guide cannula 9 mm in length was implanted into the lateral brain ventricle (0.3
mm posterior and 1 mm lateral relative to bregma, and 3 mm below the surface of the skull).
The position of the cannula was verified at the end of the experiments by dye administration
before animals were killed.
Honokiol or its vehicle was administered icv. at 9:00AM and food intake was measure for
the subsequent 8 hours. 2 μl of stock solution of 37.6 mM honokiol (Wako Chemical
Company, Tokyo, Japan) dissolved in 100 μl ethanol that was further dissolved in 1ml of
intralipid was injected14.
5μM H2O2 in 2 μl saline was injected icv. of lean mice. Saline was used as vehicle.
Rebound feeding after a 16h fast was analyzed. The same dose of H2O2 (and vehicle) was
also injected icv. to DIO female mice (n=6) 3 times, the injections 8 hours apart. Daily food
intake was measured before and after the treatment. In a subset of these mice, we injected
intrapertioneally 3μg/g body weight recombinant leptin dissolved in PBS. Animals were
killed 45 minutes later and processed for pStat3 (Cell Signaling Technology Inc., Danvers,
MA) and POMC immunolabeling,
PPARγ agonists (rosiglitazone; Enzo Life Sciences Inc., Farmingdale, NY, USA) and
antagonist GW9662 (2-chloro-5-nitrobenzanilide) were purchased from Alexis
Biochemicals and dissolved in dimethyl sulfoxide (DMSO) in saline (1:3 ratio). 0.5mg of
rosiglitazone or GW9662 in 2 μl of vehicle was injected into i.c.v. twice daily (9:00AM and
6:00 PM) for 7 days.
In sets females (n=6), after the 5th days of rosiglitazone treatment, H2O2 (5μM H2O2 in 2
μl) or saline was also administered icv. to animals in association with rosiglitazone
treatment at days 6 and 7. In other sets of females (n=6), after the 5th day of GW9662
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treatment, honokiol or its vehicle was also administered in association with the GW9662
treatments at days 6 and 7. Daily food intake was monitored and analyzed at days 5 and 7 in
all groups.
c-fos staining in NPY and POMC neurons
NPY GFP or POMC GFP and mice were treated with honokiol or vehicle and rapidly
perfused 1 hour later. c-fos immunofluorescence staining was carried out as described
before.17
Electrophysiology
Whole cell recording was made in POMC-GFP neurons in the arcuate nucleus (ARC) of the
hypothalamus as described previously24. For firing rate analysis in older DIO mice, we used
extracellular recordings from GFP labeled NPY or POMC cells.
DHE
ROS levels in identified POMC GFP neurons were measured by injecting dihydroethidium
(DHE) as described before.1
Leptin treatment of ob/ob animals
Alzet 2002 mini-osmotic pumps (Alza, Palo Alto, CA) were implanted into 8 weeks old
obese transgenic mice subcutaneously under anesthesia10. Pumps were filled with either
PBS (control) or 420 ng/μl leptin (Amgen, Thousand Oaks, CA). Pumps were incubated the
night before at 37°C in sterile 0.9% NaCl. Animals and food were weighted daily at midday.
Animals were sacrificed at 48 hours after implantation and 3 hours after DHE injections.
Measurement of leptin
Blood levels of leptin were measured by ELISA using commercially available Leptin Elisa
Kit.
Mitochondria and peroxisome counts
Animals were perfused and their brains were processed for GFP immunolabeling for
electron microscopic examination as described before.1
Cell Culture
The POMC- and AgRP-expressing hypothalamic neuronal cell lines were cultured as
previously described25. The culture media contained 0.5 mM glucose with or without 10 μM
pioglitazone (Sigma) for 24 hrs.
Real time PCR
RNA from hypothalamus or cultures was isolated using RNeasy Micro Kit (Qiagen) and
reverse transcribed to cDNA using MultiScribe Reverse Transcriptase (Applied
Biosystems). Quantitative PCR was performed with SYBR Green I Master or Probe Master
using LightCycler 480 Real time PCR system (Roche).
PPARγ NKO mice
Mice with neuron-specific PPARγ (PPARγ NKO) were generated as described recently.31
Sections from 14 week old mice with or without 2 weeks on HFD were processed for catalse
immunocytochemistry.
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All data are expressed as the mean ± sem. The means between two groups were analysed by
student t-test and between more than two groups and two genotypes by two-way ANOVA
followed by Bonferroni posthoc tests unless otherwise stated. Significance was taken at
p<0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Honokiol suppresses while H2O2 increases anorexigenic melanocortin tone and related
feeding
a: Fluorescence double labeling for c-fos (red nuclei) and GFP (green cell bodies) shows
colocalization of c-fos with GFP (white arrows) in vehicle- and honokiol-treated animals.
Bar scale on upper right panel of a indicates 100 μm for all 4 panels.
b: Honokiol treatment elevated the percent of c-fos/NPY-GFP double labeled neurons
compared to vehicle controls. Honokiol treatment decreased the percentage of c-fos/POMC-
GFP double labeled cells. * indicates P<0.05.
c: Food intake was significantly induced by icv. honokiol treatment.* P<0.05.
d: Upper panel: H2O2 significantly (*P<0.05) depolarized membrane potential of POMC-
GFP neurons an event that was rapidly reversed by washout. Control values indicate firing
of POMC neuron when exposed to vehicle. Lower panel: H2O2 significantly increased
(P<0.05) the firing frequency of arcuate nucleus POMC-GFP neurons, and event that was
reversed by washout. Control values indicate firing of POMC neuron when exposed to
vehicle.
e: Icv. administration of H202 significantly reduced food intake of mice 1h (*P<0.05), 2h
(*P<0.05), 4h (*P<0.05) and 8h (*P<0.05) subsequent to injections. Control animals were
injected with equivalent amount of vehicle.
f: DHE (red fluorescence) in POMC neurons (green fluorescence) of ob/ob, fasted lean, fed
lean and diet-induced obese (DIO) mice.
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g: Quantification of DHE in POMC neurons indicated the highest level of ROS production
in POMC neurons of DIO and fed lean mice compared to fasted lean and ob/ob mice.
*indicates significant (P<0.05) difference compared to ob/ob values. # indicates significant
(P<0.05) difference compared to fasted lean values. There was no significant difference
between fed and DIO values.
h: Leptin levels were not detectable in ob/ob mice. Leptin levels were significantly higher in
fed animals compared to fasted values (#: P<0.05). DIO animals had leptin levels that were
significantly higher compared to fed ($: P<0.05) and fasted values (#: P<0.05). * indicates
significant (P<0.05) difference compared to ob/ob values.
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Fig. 2. Peroxisome proliferation in POMC neurons
a: Electron micrographs showing representative section of POMC-GFP perykarya in the
arcuate nucleus from fasted lean (upper left panel), ob/ob (lower left panel), fed lean (upper
middle panel) and DIO (lower middle panel). White arrows on the middle panels point to
peroxisomes. The upper right and lower right panels are high power magnifications of
peroxisomes from the fed and DIO panels, respectively. Bar scale on upper left panel
indicate 1 μm for left and middle panels. Bar scale on lower right panel indicates 500 nm for
the right panels.
b: Mitochondria number was the highest in POMC neurons of fed and DIO mice compared
to fasted and ob/ob values. *: significantly different (P<0.05) from ob/ob values. #:
significantly (P<0.05) different from fasted values.
c: Highest number of peroxisomes in POMC neurons was in DIO animals. Significantly
lower numbers of peroxisomes were detected in fed and fasted animals, while no
peroxisomes were detected in POMC neurons of ob/ob animals. *: significantly different
(P<0.05) from ob/ob values. #: significantly (P<0.05) different from fasted values. $:
significantly (P<0.05) different from fed values.
d: PCR analyzes of PPARα, δ and γ showes that absolute levels of PPARγ is several fold
higher than transcripts of PPARα and δ in the hypothalamus.
e: Real time PCR analyzes of PPARα, δ and γ and various other gene transcripts related to
PPAR signaling and cellular metabolism in DIO hypothalamus relative to lean control
values. LPL: lipoprotein lipase, FASN: fatty acid synthase, LXRa: liver X receptor alpha,
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FABP1: fatty acid binding protein 1, CIDEA: cell death-inducing DFFA-like effector a,
ADFP/PLIN2: adipose differentiation related protein/perilipin 2, GCK: glucokinase. Results
are shown as mean ± SEM. The comparison of different groups was carried out using two-
tailed unpaired Student’s t-test. * indicates P<0.05.
f: PPARγ mRNA is expressed in POMC neuronal cell line mHypoA-2/28, and its relative
expression level did not change after pioglitazone treatment (pio).
g: Pioglitazone induced the expression of the PPARγ target gene, Gpd1 in the POMC-
expressing hypothalamic cell line.
h: Pioglitazone induced the expression of the PPARγ target gene, Fabp4 in the AgRP-
expressing hypothalamic cell line.
i: Pioglitazone induced the expression of the PPARγ target gene, Pin2 in the AgRP-
expressing hypothalamic cell line.
j: Real time PCR analyzes of PPARα, δ and γ and various other gene transcripts related to
PPAR signaling and cellular metabolism in ob/ob hypothalamus relative to wild type
controls. LPL: lipoprotein lipase, FASN: fatty acid synthase, LXRa: liver X receptor alpha,
FABP1: fatty acid binding protein 1, CIDEA: cell death-inducing DFFA-like effector a,
ADFP/PLIN2: adipose differentiation related protein/perilipin 2, GCK: glucokinase. Results
are shown as mean ± SEM. The comparison of different groups was carried out using two-
tailed unpaired Student’s t-test. * indicates P<0.05.
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Fig. 3. Peroxisome proliferation in POMC neurons is associated with altered feeding
a-d: Electron micrographs with fluorescence inserts of POMC neurons from lean vehicle-
treated (upper left panel), lean rosiglitazone-treated (upper right panel), DIO-vehicle treated
(lower left panel) and DIO GW9662-treated (lower right panel) mice. On the electron
micrographs, blue arrows point to peroxisomes. On the fluorescent inserts, red labeling
indicated DHE in green POMC-GFP neurons. Bar scale on the upper left electron
micrograph indicates 1 μm for all EM panels; bar scale on the fluorescent insert of the upper
left panel indicate 10 μm for all inserts.
e: Rosiglitazone induced increase in peroxisome number in POMC neurons of lean animals
on high fat diet. On the other hand, treatment of DIO mice with the PPARγ antagonist,
GW9662, decreased peroxisome number in POMC neurons. *: P<0.05).
f: DHE levels were decreased in lean animals treated with rosiglitazone, while DIO animals
treated with GW9662 had elevated DHE counts. *: P<0.05).
g: Treatment of lean mice consuming normal chow with rosiglitazone, daily food intake of
animals was significantly higher compared to vehicle-treated values. GW9662 treatment of
DIO mice consuming high fat diet resulted in a decline in daily food intake. *: P<0.05.
h: Double immunofluorescence labeling for c-fos (red) and POMC (green) from control
DIO (upper left panel), rosigliatzone-treated (upper right panel), GW9662-treated (lower left
panel) and H2O2-treated (lower right panel) high fat-fed animals. Bar scale on lowe left
panel represents 100 μm for all panels of h.
i: Bar graphs showing the percentage of c-fos immunolabeled POMC neurons in the
different experimental groups. * indicates significant (P<0.05) difference compared to DIO
control values; # indicates significant (P<0.05) differences compared to values of
rosiglitazone treated animals.
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Fig. 4. GW9662 reverses DIO-triggered electric activity of the melanocortin system and ROS
regulates feeding behavior in DIO animals
a: Firing rate of DIO NPY/AgRP neurons is significantly decreased (*:P<0.05) by GW9662
treatment.
b: Firing rate of DIO POMC neurons is significantly increased (*:P<0.05) by GW9662
treatment.
c: GW9662 treatment increased the percentage of silent DIO NPY/AgRP neurons.
d: GW9662 treatment decreased the percentage of silent DIO POMC neurons.
e: Rosiglitazone induces food intake in lean animals. Left column indicates daily food intake
after 5 days on high fat diet. Middle column shows mean daily food intake after 5 days
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treatment with rosiglitazone. Right column indicates daily food intake after 7 days
rosiglitazone treatment. Red bar graph on right indicates daily food intake of animals with 7
day rosiglitazone treatment with H202 in the last 2 days of the 7 day treatment. * indicates
significant (P<0.05) difference relative to values before rosiglitazone treatment. # indicates
significant (P<0.05) differences between daily food intake values after 5 day treatment with
rosiglitazone treatments. $ indicates significant (P<0.05) differences between 7 day
treatment values.
f: GW9662 induces suppression of food intake in DIO animals fed a high fat diet. Left
column indicates daily food intake at the beginning of treatment (day 0). Middle column
shows mean food intake after 5 days treatment with GW9662. Right column indicates daily
food intake after 7 days DW9662 treatment. Green bar graph on right indicates daily food
intake of animals with 7 day GW9662 treatment with honokiol in the last 2 days of the 7 day
treatment. * indicates significant (P<0.05) difference relative to values before GW9662
treatment. # indicates significant (P<0.05) differences between daily food intake values after
5 day treatment with GW9662 treatments. $ indicates significant (P<0.05) differences
between 7 day treatment values.
g: 2 days icv. H202 treatment alone resulted in significantly (P<0.05) decreased daily food
intake of DIO animals compared to vehicle treated controls.
h: Photomicrographs of pStat3 (red; asterisks) and POMC double immuno-labeled
hypothalamic sections from leptin treated DIO mice co-treated with vehicle or H2O2 after
peripheral leptin injections. There was significantly (P<0.05) higher percentage of POMC
neurons with pStat3 labeled nucleus (arrow) in the arcuate nucleus of H2O2 treated mice
compared to vehicle-treated controls. Bar scale represents 100 μm for both panels.
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